This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (40)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Stephen B. Tucker, MD; R. K. Winkelmann, MD, PhD

Arch Dermatol. 1976;112(7):958-961.

Abstract
Five cases of Kaposi sarcoma with vinblastine sulfate treatment were compared with 18 cases reported in the literature. Our experience with a low-dosage schedule emphasizes that toxicity is not necessary for a favorable result. Vinblastine seems to be an effective treatment for Kaposi sarcoma and, in selected cases, may supplement radiation therapy or be used alone.

(Arch Dermatol 112:958-961, 1976)

Author Affiliations
From the Mayo Clinic and Mayo Foundation, Rochester, Minn.

Footnotes
Accepted for publication Sept 15, 1975.

Reprint requests to Section of Publications, Mayo Clinic, 200 First St SW, Rochester, MN 55901 (Dr Tucker).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Vinblastine Therapy for Kaposi's Sarcoma in the Acquired Immunodeficiency Syndrome
VOLBERDING et al.
ANN INTERN MED 1985;103:335-338.
ABSTRACT  

Kaposi's Sarcoma Limited to the Facial Skin
Vogler et al.
Arch Dermatol 1984;120:398-400.
ABSTRACT  

Primary Kaposi's Sarcoma of the Head and Neck
GNEPP et al.
ANN INTERN MED 1984;100:107-114.
ABSTRACT  

The Acquired Immunodeficiency Syndrome
GOTTLIEB et al.
ANN INTERN MED 1983;99:208-220.
ABSTRACT  

Treatment of Cutaneous Kaposi's Sarcoma With Intralesional Vincristine
Odom and Goette
Arch Dermatol 1978;114:1693-1694.
ABSTRACT